Inspira Technologies Manufactures Vortx Blood Oxygenator, a unique technology for saturating blood with oxygen and removing carbon dioxide

Inspira Technologies OXY B.H.N. Ltd., a company aiming to revolutionise acute respiratory care, has announced the development of the Vortx Blood Oxygenator, an Augmented Respiration Technology based on a new breakthrough technological approach, designed to mimic the function of the lung by efficiently saturating the blood with oxygen and removing carbon dioxide. The Vortx Blood Oxygenator, which is currently in development, has the potential to revolutionise the perfusionists systems market, which is currently valued at $1.16 billion in 2023, with a target of 2 million extracorporeal procedures performed annually, including open-heart surgeries and ECMO treatment.

The business forecasts that this market segment will increase significantly as a result of the additional market opportunity represented by the possible new treatment category offered by our flagship Inspira ART. The Vortx Blood Oxygenator is intended to increase hemodynamic performance while decreasing oxygenator failure. The present blood oxygenator market3 is based on hollow fibre membrane technology, which has been linked to medical issues such as device failure, coagulation (clotting), and haemolysis (damage or destruction of red blood cells), all of which pose dangers and have an influence on patient outcomes.

The Vortx Blood Oxygenator is being developed as a stand-alone disposable unit that will be compatible with both our flagship Inspira ART system and the Alice device. The Vortx Blood Oxygenator is scheduled to be submitted to the US Food and Drug Administration (FDA) for regulatory assessment and clearance after development and testing are completed. Dr. Daniella Yeheskely-Hayon, Inspira Technologies’ chief technology officer, stated: “Having vast experience in blood oxygenation development, my team and I are excited to lead the development of the revolutionary Vortx Blood Oxygenator.

Inspira Technologies’ highly advanced testing laboratories are the core to the development of this new technological approach. Currently, available blood oxygenators on the market are based on the same hollow fiber membrane technology. Our Vortx focuses on a totally new technological approach.” Inspira Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (Inspira ART), designed to rebalance patient oxygen saturation levels.